USA – FDA eases labeling, clarifies IVD requirements in COVID transition guidances
The US Food and Drug Administration (FDA) has made several changes to its guidances for transitioning medical devices and diagnostics from COVID-related authorization to...
Europe – 38ème organisme notifié au titre du Règlement 2017/745
38ème organisme notifié au titre du Règlement 2017/745
Europe – Le règlement (UE) 2023/607
Le règlement (UE) 2023/607, publié au JOUE, modifie les dispositions transitoires relatives à certains dispositifs médicaux et à certains dispositifs médicaux de diagnostic in...
Europe – Publication of the Third Edition of the “Clinical Evidence Requirements under EU...
We are pleased to announce the publication of the Third Edition of the “Clinical Evidence Requirements under EU In Vitro Diagnostics Regulation” Regulatory eBook.
The Questions and Answers eBook was developed by...
Europe – European Regulators Move to Increase Notified Body Capacity
The European Commission (EC) has taken new measures to relieve some of the pressure on Notified Bodies and free up capacity to perform medical...
USA – New rule directs mammography facilities to tell patients about breast density
The US Food and Drug Administration (FDA) has issued a final rule intended to ensure patients are better informed about their breast tissue density...
Europe – Advisory group urges UK to ‘rapidly explore’ recognition of US device approvals
A group formed to advise the UK government on the regulation of medical devices is pushing for officials to “rapidly explore” building an equivalence...
France – Radiation de 2 DM essentiels dans la prise en charge de l’AVC...
Au 1er mars 2023, deux catégories de dispositifs médicaux innovants seront radiées du Titre V de la LPPR* les cathéters de thrombo-aspiration (AVC) et les guides...
Europe – Council votes unanimously to extend MDR deadlines
The European Council (EC) has approved a measure to extend the transition period for medical devices under the Medical Devices Regulation (MDR) and to...
France – Arrêté du 22 février 2023 portant approbation du référentiel d’interopérabilité et de...
Le ministre de la santé et de la prévention,
Vu le règlement (UE) 2016/679 du Parlement européen et du Conseil du 27 avril 2016 relatif...
